b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31612319</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1432-1335</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>145</Volume>\n                    <Issue>12</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Dec</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of cancer research and clinical oncology</Title>\n                <ISOAbbreviation>J. Cancer Res. Clin. Oncol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2969-2982</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00432-019-03052-5</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Non-canonical NF\xce\xbaB (NC-NF\xce\xbaB) pathway plays an influential role in metastasis, which promotes cancer proliferation and progression. The aim of the study was to examine the expression of NC-NF\xce\xbaB proteins and their correlation with clinicopathological factors associated with metastatic cases of uveal melanoma (UM) and with the patient outcome.</AbstractText>\n                <AbstractText Label="METHOD" NlmCategory="METHODS">Expression of NC-NF\xce\xbaB proteins (p52, RelB, and co-expression of p52/RelB) was evaluated in 75 formalin-fixed cases of uveal melanoma by immunohistochemistry. Validation of nuclear immunoreactivity was done by western blotting. Transcriptional status of NC-NF\xce\xbaB genes was assessed in 60 fresh tumor tissues by quantitative real-time PCR. Co-immunoprecipitation was performed to determine the presence of native p52/RelB heterodimer in UM. Prognostic relevance was determined using Cox proportional hazard and Kaplan-Meier methods.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Immunohistochemical expression of p52, RelB, and their co-expression was observed in 81%, 68.7%, 56.2% of metastatic cases, respectively, while their expression was seen only in 38%, 33% and 30% of non-metastatic cases. Loss of BAP-1 was correlated with expression of p52 and RelB proteins. Co-immunoprecipitation assay confirmed the putative interaction of p52 with RelB protein in metastatic cases of uveal melanoma. Co-expression of p52/RelB and expression of p52 protein was significantly correlated with decreased metastasis-free survival (MFS) (p\xe2\x80\x89=\xe2\x80\x890.004; p\xe2\x80\x89=\xe2\x80\x890.002) and overall survival (OS) (p\xe2\x80\x89=\xe2\x80\x890.004; p\xe2\x80\x89=\xe2\x80\x890.032), while the RelB expression only correlated with reduced MFS (p\xe2\x80\x89=\xe2\x80\x890.003).</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data showed that non-canonical NF\xce\xbaB proteins were significantly higher in metastatic cases and associated with poor outcome of the patients. Furthermore, the p52 protein could be used as a potential therapeutic biomarker for metastatic cases in uveal melanoma.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Singh</LastName>\n                    <ForeName>Mithalesh Kumar</ForeName>\n                    <Initials>MK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Singh</LastName>\n                    <ForeName>Lata</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biosciences, JMI, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chosdol</LastName>\n                    <ForeName>Kunzang</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biochemistry, AIIMS, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pushker</LastName>\n                    <ForeName>Neelam</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Functional Genomics Unit, Institute of Genomics and Integrative Biology, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Saini</LastName>\n                    <ForeName>Neeru</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Functional Genomics Unit, Institute of Genomics and Integrative Biology, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Meel</LastName>\n                    <ForeName>Rachna</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Functional Genomics Unit, Institute of Genomics and Integrative Biology, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bakhshi</LastName>\n                    <ForeName>Sameer</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, IRCH, AIIMS, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sen</LastName>\n                    <ForeName>Seema</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kashyap</LastName>\n                    <ForeName>Seema</ForeName>\n                    <Initials>S</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8746-9017</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. dr_skashyap@hotmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>14</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>J Cancer Res Clin Oncol</MedlineTA>\n            <NlmUniqueID>7902060</NlmUniqueID>\n            <ISSNLinking>0171-5216</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D052003">NF-kappa B p52 Subunit</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C497593">RELB protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>147337-75-5</RegistryNumber>\n                <NameOfSubstance UI="D051841">Transcription Factor RelB</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <SupplMeshList>\n            <SupplMeshName Type="Disease" UI="C536494">Uveal melanoma</SupplMeshName>\n        </SupplMeshList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D052003" MajorTopicYN="N">NF-kappa B p52 Subunit</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051841" MajorTopicYN="N">Transcription Factor RelB</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014604" MajorTopicYN="N">Uveal Neoplasms</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Co-expression</Keyword>\n            <Keyword MajorTopicYN="N">Metastasis</Keyword>\n            <Keyword MajorTopicYN="N">RelB</Keyword>\n            <Keyword MajorTopicYN="N">Uveal melanoma</Keyword>\n            <Keyword MajorTopicYN="N">p52</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31612319</ArticleId>\n            <ArticleId IdType="doi">10.1007/s00432-019-03052-5</ArticleId>\n            <ArticleId IdType="pii">10.1007/s00432-019-03052-5</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer. 1993 Oct 1;72(7):2219-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7848381</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16141321</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell. 2003 Jun;11(6):1563-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12820969</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Ophthalmol. 2015 Apr;133(4):376-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25555246</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2016 Jul 26;115(3):322-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27404455</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4890-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17962435</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Pathol. 2014 Oct;27(10):1321-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24633195</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):421-427</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29185101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pigment Cell Res. 2006 Apr;19(2):112-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16524427</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Immunol Immunother. 2017 Jul;66(7):903-912</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28391358</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1811-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19892878</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int Ophthalmol Clin. 2006 Winter;46(1):167-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16365562</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Indian J Ophthalmol. 2015 Feb;63(2):93-102</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25827538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Biol. 2005 Nov;25(22):10136-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16260626</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2002 Apr;2(4):301-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12001991</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18234992</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AJR Am J Roentgenol. 1991 Dec;157(6):1279-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1950883</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2011 Jul 19;12(8):715-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21772280</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Urol Int. 2018;101(2):190-196</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30089311</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14578381</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Innate Immun. 2012;4(5-6):454-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22302072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Endocrinol. 2012 Aug;26(8):1356-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22734038</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2001 Dec 14;107(6):763-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11747812</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Physiol. 2009 Sep;220(3):593-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19373868</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2010 Dec 3;330(6009):1410-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21051595</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Biochem. 2010 Mar;336(1-2):25-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19823771</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2017 Oct;14(4):4037-4042</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28959363</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Immunol. 2010 Apr;22(2):231-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20144856</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2006 Oct 30;25(51):6817-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17072330</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thorac Cancer. 2016 Jul;7(4):415-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27385983</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Carcinogenesis. 2003 Mar;24(3):377-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12663495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ophthalmology. 2011 Sep;118(9):1881-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21704381</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'